Wayne Greene
Payments from drug & device makers
Across 169 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$1K
- Biohaven Pharmaceuticals, Inc.$412
- Novartis$272
- Johnson & Johnson$224
- AstraZeneca$172
- UCB, Inc.$169
- plus $1K from 24 others
What the payments were for
- Consulting fees$45013%
- Speaking & faculty fees$441%
- Food & beverage$2,73082%
- Education$1214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 37 | $1,026 |
| Biohaven Pharmaceuticals, Inc. | 22 | $412 |
| Novartis | 17 | $272 |
| Johnson & Johnson | 4 | $224 |
| AstraZeneca | 4 | $172 |
| UCB, Inc. | 12 | $169 |
| Neurocrine Biosciences, Inc. | 9 | $118 |
| SK Life Science, Inc. | 4 | $100 |
| AbbVie | 4 | $98 |
| Eisai Inc. | 6 | $79 |
| Lilly USA, LLC | 6 | $77 |
| Sunovion Pharmaceuticals Inc. | 6 | $68 |
| Amgen | 5 | $64 |
| Teva Pharmaceuticals USA, Inc. | 4 | $53 |
| Supernus Pharmaceuticals, Inc. | 4 | $51 |
| Bristol Myers Squibb | 3 | $44 |
| Acorda Therapeutics, Inc | 3 | $44 |
| Acadia Pharmaceuticals Inc | 3 | $39 |
| Aprecia Pharmaceuticals, LLC | 2 | $31 |
| EMD Serono, Inc. | 2 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Sanofi | 2 | $26 |
| Boston Scientific | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Argenx US, Inc. | 1 | $13 |
| Adamas Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYSABRI$450
- Ponvory$125
- NURTEC ODT$120
- SOLIRIS$113
- Vumerity$100
How this compares
$3,344 in reported general payments places this provider in the 55th percentile of 521 neurology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 19 | $1,081 |
| Carbamazepine | 13 | $312 |
| Levetiracetam | 11 | $156 |
Paid to pharmacies, not to this prescriber.
Other neurology in Dover
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.